Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers.

Current opinion in urology - 1 Sept 2022

Tiwari Raj, Clark Roderick, Fleshner Neil

Abstract excerpt

PURPOSE OF REVIEW: Men with high-risk germline mutations are at significantly higher risk of developing and dying from prostate cancer. Current screening and treatment paradigms may lead to missed opportunities for cure. Herein we review the current literature on prevention, screening and treatment of these carriers and explore the potential role of prophylactic prostatectomy in primary prevention of prostate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Germ-Line Mutation
Share to Mutation
Share to Primary Prevention

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prostate-Specific Antigen

Share to Prostatectomy

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 35855558
DOI: 10.1097/MOU.0000000000001019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers.PMID 35855558Read ↗

Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.Semantic proximity Read ↗

Precision intervention for prostate cancer: Re-evaluating who is at risk.Semantic proximity Read ↗

Prostate Cancer Screening in a New Era of Genetics.Semantic proximity Read ↗

Men with a susceptibility to prostate cancer and the role of genetic based screeningSemantic proximity Read ↗

Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.Semantic proximity Read ↗

Prostate cancer screening in BRCA and Lynch syndrome mutation carriers.Semantic proximity Read ↗

Germline BRCA mutation in male carriers-ripe for precision oncology?Semantic proximity Read ↗

Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.Semantic proximity Read ↗

Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study.Semantic proximity Read ↗

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.Semantic proximity Read ↗

High-Grade Prostate Adenocarcinoma in a BRCA2 Germline Mutation Carrier: Precision Oncology and Familial Cascade Testing: a case reportSemantic proximity Read ↗

Germline mutations and prostate cancer: is it time to change treatment algorithms?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.